{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T12:59:24Z","timestamp":1785416364279,"version":"3.56.0"},"reference-count":57,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,1,6]],"date-time":"2023-01-06T00:00:00Z","timestamp":1672963200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Microbiol."],"abstract":"<jats:p>Myasthenia gravis (MG) is an autoimmune disease caused by autoantibodies that is dependent on T-cell immunity and complement participation and mainly involves neuromuscular junctions. In this study, 30 patients with myasthenia gravis were selected and divided into pretreatment (Case group) and posttreatment (Treatment group) and 30 healthy volunteers (CON group) were included. Among them, the treatment group was treated with Modified Buzhong Yiqi Decoction (MBZYQD), and the levels of antibodies such as AChR, Musk and Titin in blood and intestinal microbiota were compared before treatment (Case group), after treatment (Treatment group) and in healthy volunteers (CON group). The results showed that after treatment with MBZYQD, the antibody levels of AChR, MuSK, and Titin and the inflammatory factor level of IL-6, IL-1\u03b2, and IL-22 in MG patients decreased significantly and nearly returned to a healthy level. In addition, after treatment with MBZYQD, the diversity, structure and function of intestinal microorganisms in MG patients also recovered to a healthy level. At the phylum level, the relative abundance of Proteobacteria in the Case group increased significantly, accompanied by a significant decrease in the relative abundance of Bacteroides compared with that in the CON group, the relative abundance of Proteobacteria and Bacteroides in the Treatment group was similar to that in the CON group. At the genus level, the relative abundance of <jats:italic>Shigella<\/jats:italic> in the Case group was significantly increased, accompanied by a significant decrease in the relative abundance of <jats:italic>Prevotella<\/jats:italic>, and the relative abundance of <jats:italic>Shigella<\/jats:italic> and <jats:italic>Prevotella<\/jats:italic> in Treatment group was similar to that in the CON group. Moreover, the fluorobenzoate degradation pathway (KO00364) was significantly increased in the Case group, while this pathway was significantly decreased in the Treatment group. In conclusion, MBZYQD can improve the immune function of the host by regulating the diversity, structure and function of the intestinal microbiota to treat myasthenia gravis.<\/jats:p>","DOI":"10.3389\/fmicb.2022.1082565","type":"journal-article","created":{"date-parts":[[2023,1,6]],"date-time":"2023-01-06T13:19:26Z","timestamp":1673011166000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":8,"title":["Traditional Chinese medicine improves myasthenia gravis by regulating the symbiotic homeostasis of the intestinal microbiota and host"],"prefix":"10.3389","volume":"13","author":[{"given":"Mingli","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanzhao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhijuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanli","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianxi","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,1,6]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1038\/nature12331","article-title":"Treg induction by a rationally selected mixture of clostridia strains from the human microbiota","volume":"500","author":"Atarashi","year":"2013","journal-title":"Nature"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1080\/07853890.2016.1222449","article-title":"Is there a role for gut microbiota in type 1 diabetes pathogenesis?","volume":"49","author":"Bibb\u00f2","year":"2017","journal-title":"Ann. Med."},{"key":"ref3","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.neurobiolaging.2016.08.019","article-title":"Association of brain amyloidosis with pro-inflammatory gut bacterial taxa and peripheral inflammation markers in cognitively impaired elderly","volume":"49","author":"Cattaneo","year":"2017","journal-title":"Neurobiol. Aging"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"e52119","DOI":"10.1371\/journal.pone.0052119","article-title":"Prophylactic effect of probiotics on the development of experimental autoimmune myasthenia gravis","volume":"7","author":"Chae","year":"2012","journal-title":"PLoS One"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"803101","DOI":"10.3389\/fimmu.2021.803101","article-title":"Gut microbiota as regulators of Th17\/Treg balance in patients with myasthenia gravis","volume":"12","author":"Chen","year":"2021","journal-title":"Front. Immunol."},{"key":"ref6","doi-asserted-by":"publisher","first-page":"2455","DOI":"10.1021\/acs.jcim.5b00449","article-title":"Discovering new acetylcholinesterase inhibitors by mining the Buzhongyiqi decoction recipe data","volume":"55","author":"Cui","year":"2015","journal-title":"J. Chem. Inf. Model."},{"key":"ref7","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1111\/cei.13158","article-title":"The microbiome in autoimmune diseases","volume":"195","author":"De Luca","year":"2019","journal-title":"Clin. Exp. Immunol."},{"key":"ref8","doi-asserted-by":"publisher","first-page":"12836","DOI":"10.3390\/ijerph182312836","article-title":"Intestinal barrier in human health and disease","volume":"18","author":"Di Tommaso","year":"2021","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.2174\/1871530319666190529101816","article-title":"The role of the status of selected micronutrients in shaping the immune function","volume":"19","author":"Elmadfa","year":"2019","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/19490976.2020.1826746","article-title":"B. adolescentis ameliorates chronic colitis by regulating Treg\/Th2 response and gut microbiota remodeling","volume":"13","author":"Fan","year":"2021","journal-title":"Gut Microbes"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.ncl.2018.01.011","article-title":"Treatment of myasthenia gravis","volume":"36","author":"Farmakidis","year":"2018","journal-title":"Neurol. Clin."},{"key":"ref12","doi-asserted-by":"publisher","first-page":"2089","DOI":"10.1053\/j.gastro.2021.02.013","article-title":"Functional restoration of bacteriomes and viromes by fecal microbiota transplantation","volume":"160","author":"Fujimoto","year":"2021","journal-title":"Gastroenterology"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s00281-014-0455-3","article-title":"Commensal microbiota regulates T cell fate decision in the gut","volume":"37","author":"Furusawa","year":"2015","journal-title":"Semin. Immunopathol."},{"key":"ref14","doi-asserted-by":"publisher","first-page":"Cd002277","DOI":"10.1002\/14651858.CD002277.pub4","article-title":"Intravenous immunoglobulin for myasthenia gravis","volume":"12","author":"Gajdos","year":"2012","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref15","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/j.acthis.2016.06.004","article-title":"Indirubin ameliorates dextran sulfate sodium-induced ulcerative colitis in mice through the inhibition of inflammation and the induction of Foxp3-expressing regulatory T cells","volume":"118","author":"Gao","year":"2016","journal-title":"Acta Histochem."},{"key":"ref16","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/s1474-4422(15)00145-3","article-title":"Myasthenia gravis: subgroup classification and therapeutic strategies","volume":"14","author":"Gilhus","year":"2015","journal-title":"Lancet Neurol."},{"key":"ref17","doi-asserted-by":"publisher","first-page":"353","DOI":"10.3109\/08916930903555943","article-title":"Antibody effector mechanisms in myasthenia gravis-pathogenesis at the neuromuscular junction","volume":"43","author":"Gomez","year":"2010","journal-title":"Autoimmunity"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1016\/s1473-3099(15)00293-5","article-title":"A comprehensive repertoire of prokaryotic species identified in human beings","volume":"15","author":"Hugon","year":"2015","journal-title":"Lancet Infect. Dis."},{"key":"ref19","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1002\/ptr.6227","article-title":"Chemo-preventive and therapeutic effect of the dietary flavonoid kaempferol: a comprehensive review","volume":"33","author":"Imran","year":"2019","journal-title":"Phytother. Res."},{"key":"ref20","doi-asserted-by":"publisher","first-page":"e13677","DOI":"10.1097\/md.0000000000013677","article-title":"Modified Buzhong Yiqi decoction for myasthenia gravis: a systematic review protocol","volume":"97","author":"Jiang","year":"2018","journal-title":"Medicine (Baltimore)"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/nri3430","article-title":"Role of the gut microbiota in immunity and inflammatory disease","volume":"13","author":"Kamada","year":"2013","journal-title":"Nat. Rev. Immunol."},{"key":"ref22","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1016\/j.jaci.2020.07.027","article-title":"Mutual regulation of metabolic processes and proinflammatory NF-\u03baB signaling","volume":"146","author":"Kracht","year":"2020","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref23","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.1073\/pnas.0904055107","article-title":"Generation of regulatory dendritic cells and CD4+Foxp3+ T cells by probiotics administration suppresses immune disorders","volume":"107","author":"Kwon","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"ref24","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.jaut.2007.07.021","article-title":"Regulatory T cells in the prevention of mucosal inflammatory diseases: patrolling the border","volume":"29","author":"Lan","year":"2007","journal-title":"J. Autoimmun."},{"key":"ref25","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.1080\/19490976.2020.1770042","article-title":"The interplay between the gut microbiota and NLRP3 activation affects the severity of acute pancreatitis in mice","volume":"11","author":"Li","year":"2020","journal-title":"Gut Microbes"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"e27688","DOI":"10.1097\/md.0000000000027688","article-title":"Effect of Buzhong Yiqi decoction on anti-acetylcholine receptor antibody and clinical status in juvenile ocular myasthenia gravis","volume":"100","author":"Li","year":"2021","journal-title":"Medicine (Baltimore)"},{"key":"ref27","first-page":"271","article-title":"Clinical study of strengthening pi and nourishing shen therapy combined with Western medicine on patients with glucocorticoid resistant myasthenia gravis","volume":"30","author":"Liu","year":"2010","journal-title":"Zhongguo Zhong Xi Yi Jie He Za Zhi"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1186\/s12916-021-02034-0","article-title":"Metagenome-wide association study of gut microbiome revealed potential microbial marker set for diagnosis of pediatric myasthenia gravis","volume":"19","author":"Liu","year":"2021","journal-title":"BMC Med."},{"key":"ref29","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1016\/j.celrep.2017.07.031","article-title":"Human gut-derived commensal bacteria suppress CNS inflammatory and demyelinating disease","volume":"20","author":"Mangalam","year":"2017","journal-title":"Cell Rep."},{"key":"ref30","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1097\/wco.0000000000000596","article-title":"Myasthenia gravis: from autoantibodies to therapy","volume":"31","author":"Mantegazza","year":"2018","journal-title":"Curr. Opin. Neurol."},{"key":"ref31","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/j.celrep.2015.03.049","article-title":"The gut microbiota of rural Papua new guineans: composition, diversity patterns, and ecological processes","volume":"11","author":"Mart\u00ednez","year":"2015","journal-title":"Cell Rep."},{"key":"ref32","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1111\/apt.13302","article-title":"Chemotherapy-driven dysbiosis in the intestinal microbiome","volume":"42","author":"Montassier","year":"2015","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref33","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1007\/s00115-019-00798-8","article-title":"Myasthenia gravis","volume":"90","author":"M\u00fcllges","year":"2019","journal-title":"Nervenarzt"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1038\/s41564-018-0333-1","article-title":"Gut pathobionts underlie intestinal barrier dysfunction and liver T helper 17 cell immune response in primary sclerosing cholangitis","volume":"4","author":"Nakamoto","year":"2019","journal-title":"Nat. Microbiol."},{"key":"ref35","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1212\/wnl.0000000000011124","article-title":"International consensus guidance for Management of Myasthenia Gravis: 2020 update","volume":"96","author":"Narayanaswami","year":"2021","journal-title":"Neurology"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.3389\/fimmu.2018.01584","article-title":"Microbiome and allergic diseases","volume":"9","author":"Pascal","year":"2018","journal-title":"Front. Immunol."},{"key":"ref37","doi-asserted-by":"publisher","first-page":"231","DOI":"10.3390\/nu14010231","article-title":"Curcumin supplementation (Meriva\u00ae) modulates inflammation, lipid peroxidation and gut microbiota composition in chronic kidney disease","volume":"14","author":"Pivari","year":"2022","journal-title":"Nutrients"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"2627","DOI":"10.3389\/fmicb.2018.02627","article-title":"Altered gut microbiota in myasthenia gravis","volume":"9","author":"Qiu","year":"2018","journal-title":"Front. Microbiol."},{"key":"ref39","doi-asserted-by":"publisher","first-page":"2949","DOI":"10.3389\/fimmu.2019.02949","article-title":"Therapeutic effect of Bifidobacterium administration on experimental autoimmune myasthenia gravis in Lewis rats","volume":"10","author":"Rinaldi","year":"2019","journal-title":"Front. Immunol."},{"key":"ref40","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1111\/nyas.13567","article-title":"Gut microbiota and probiotics: novel immune system modulators in myasthenia gravis?","volume":"1413","author":"Rinaldi","year":"2018","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref41","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1093\/advances\/nmz061","article-title":"Negative effects of a high-fat diet on intestinal permeability: a review","volume":"11","author":"Rohr","year":"2020","journal-title":"Adv. Nutr."},{"key":"ref42","doi-asserted-by":"publisher","first-page":"462","DOI":"10.3389\/fimmu.2019.00462","article-title":"Prevotella histicola, a human gut commensal, is as potent as COPAXONE\u00ae in an animal model of multiple sclerosis","volume":"10","author":"Shahi","year":"2019","journal-title":"Front. Immunol."},{"key":"ref43","doi-asserted-by":"publisher","first-page":"578648","DOI":"10.3389\/fimmu.2020.578648","article-title":"Human commensal Prevotella histicola ameliorates disease as effectively as interferon-Beta in the experimental autoimmune encephalomyelitis","volume":"11","author":"Shahi","year":"2020","journal-title":"Front. Immunol."},{"key":"ref44","doi-asserted-by":"publisher","first-page":"762580","DOI":"10.3389\/fimmu.2022.762580","article-title":"Indole-3-acetic acid alters intestinal microbiota and alleviates ankylosing spondylitis in mice","volume":"13","author":"Shen","year":"2022","journal-title":"Front. Immunol."},{"key":"ref45","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1111\/cei.12217","article-title":"Myasthenia gravis: an update for the clinician","volume":"175","author":"Sieb","year":"2014","journal-title":"Clin. Exp. Immunol."},{"key":"ref46","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1111\/imm.13117","article-title":"Intestinal epithelial cells: at the interface of the microbiota and mucosal immunity","volume":"158","author":"Soderholm","year":"2019","journal-title":"Immunology"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/j.cell.2020.12.011","article-title":"Infection trains the host for microbiota-enhanced resistance to pathogens","volume":"184","author":"Stacy","year":"2021","journal-title":"Cells"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/nature18847","article-title":"The microbiome and innate immunity","volume":"535","author":"Thaiss","year":"2016","journal-title":"Nature"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1093\/molbev\/msz240","article-title":"Treeio: an R package for phylogenetic tree input and output with richly annotated and associated data","volume":"37","author":"Wang","year":"2020","journal-title":"Mol. Biol. Evol."},{"key":"ref50","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1080\/13880209.2021.2010774","article-title":"Efficacy of Yougui pill combined with Buzhong Yiqi decoction in alleviating the sexual dysfunction in female rats through modulation of the gut microbiota","volume":"60","author":"Wang","year":"2022","journal-title":"Pharm. Biol."},{"key":"ref51","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1126\/science.1208344","article-title":"Linking long-term dietary patterns with gut microbial enterotypes","volume":"334","author":"Wu","year":"2011","journal-title":"Science"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"4457","DOI":"10.1038\/s41467-020-18262-6","article-title":"Intestinal microbiota-derived short-chain fatty acids regulation of immune cell IL-22 production and gut immunity","volume":"11","author":"Yang","year":"2020","journal-title":"Nat. Commun."},{"key":"ref53","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1016\/j.cell.2022.02.013","article-title":"Mucus sialylation determines intestinal host-commensal homeostasis","volume":"185","author":"Yao","year":"2022","journal-title":"Cells"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1080\/08820130802111589","article-title":"Anti-inflammatory mechanism of a folk herbal medicine, Duchesnea indica (Andr) Focke at RAW264.7 cell line","volume":"37","author":"Zhao","year":"2008","journal-title":"Immunol. Investig."},{"key":"ref55","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.intimp.2010.12.012","article-title":"Clinical efficacy and immunological impact of tacrolimus in Chinese patients with generalized myasthenia gravis","volume":"11","author":"Zhao","year":"2011","journal-title":"Int. Immunopharmacol."},{"key":"ref56","doi-asserted-by":"publisher","first-page":"1901441","DOI":"10.1002\/advs.201901441","article-title":"Perturbed microbial ecology in myasthenia gravis: evidence from the gut microbiome and fecal metabolome","volume":"6","author":"Zheng","year":"2019","journal-title":"Adv. Sci."},{"key":"ref57","doi-asserted-by":"publisher","first-page":"e24807","DOI":"10.1097\/md.0000000000024807","article-title":"Efficacy and safety of Buzhong Yiqi decoction combined with western medicine in the treatment of myasthenia gravis: a protocol for systematic review and meta-analysis","volume":"100","author":"Zong","year":"2021","journal-title":"Medicine (Baltimore)"}],"container-title":["Frontiers in Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2022.1082565\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,6]],"date-time":"2023-01-06T13:19:32Z","timestamp":1673011172000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2022.1082565\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,6]]},"references-count":57,"alternative-id":["10.3389\/fmicb.2022.1082565"],"URL":"https:\/\/doi.org\/10.3389\/fmicb.2022.1082565","relation":{},"ISSN":["1664-302X"],"issn-type":[{"value":"1664-302X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,6]]},"article-number":"1082565"}}